// App-Quantinova.ai

1414 : Validation of MRD Quantification By Flow Cytometry for Pediatric BCP ALL Relapsed Patients Treated on the Intreall Protocol

Researchers

Presenter

  • Ester Mejstrikova

Principal Investigators

  • Julie Irving

  • Leonid Karawajew

  • Renate Panzer-Grumayer

  • Barbara Buldini

  • Lisa Eyre

  • Marian Case

  • Jenny Jesson

  • Vaskar Saha

  • Nicholas Goulden

  • Jeremy Hancock

  • Arend Stackelberg

  • Sarah Lawson

  • Michael Dworzak

Medical Centers

  • Charles Univ and VFN, Prague, Czech Republic

  • Birmingham Women's NHS Foundation Trust, Birmingham, United Kingdom

  • University Hospital Motol, Prague, Czech Republic

  • CHILDREN S CANCER RESEARCH INSTITUTE, Vienna, Austria,

  • Department of Pediatrics , St. Anna Childrens Hospital and Childrens Cancer Research Institute, Vienna, Austria,

  • Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic

  • Tata Translational Cancer Research Centre, Kolkata, India

  • Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom

  • Department of Haematology, Birmingham Childrens Hospital, Birmingham, United Kingdom

  • Department of Paediatric Haematology and Oncology, CLIP Laboratory Centre, 2nd School of Medicine, Charles University, Prague, Czech Republic

  • Department of Pediatric Oncology/Hematology, Charite Medical University Berlin, Berlin, Germany.

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Bristol Genetics Laboratory, Southmead Hospital, Bristol, United Kingdom

  • Dipartimento di Salute della Donna e del Bambino, Universit di Padova, Padova, Italy

Locations

  • Czech Republic

  • Italy

  • Austria

  • Germany

  • United Kingdom

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

  • Solid malignancies

Biomarkers

  • T-cell receptor

Drug/Treatment

  • Epratuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved